Anat Eldar‐Boock
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 11
- Molecular Medicine top 5%
- Biomedical Engineering top 5%
- Nanoplatforms for cancer theranostics 9
- Pharmaceutical Science top 5%
- Microbiology top 5%
-
- Bone health and treatments 5
-
- RNA Interference and Gene Delivery 4
- Angiogenesis and VEGF in Cancer 4
-
- Cell Adhesion Molecules Research 4
-
- Radiopharmaceutical Chemistry and Applications 3
-
- Reproductive Biology and Fertility 3
Anat Eldar‐Boock
35 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 107
- Biomaterials 560
- Molecular Medicine 81
- Biomedical Engineering 689
- Pharmaceutical Science 94
- Microbiology 88
Countries citing papers authored by Anat Eldar‐Boock
This map shows the geographic impact of Anat Eldar‐Boock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anat Eldar‐Boock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anat Eldar‐Boock more than expected).
Fields of papers citing papers by Anat Eldar‐Boock
This network shows the impact of papers produced by Anat Eldar‐Boock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anat Eldar‐Boock. The network helps show where Anat Eldar‐Boock may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anat Eldar‐Boock, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 17 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2022 | 4 | |
| 5 | 2021 | 3 | |
| 6 | 2021 | 1 | |
| 7 | 2020 | 54 | |
| 8 | 2020 | 13 | |
| 9 | 2019 | 72 | |
| 10 | 2018 | 48 | |
| 11 | 2018 | 12 | |
| 12 | 2017 | 239 | |
| 13 | 2017 | 20 | |
| 14 | 2017 | 79 | |
| 15 | 2016 | 53 | |
| 16 | 2013 | 75 | |
| 17 | 2013 | 95 | |
| 18 | 2013 | 18 | |
| 19 | 2012 | 34 | |
| 20 | 2011 | 12 |
About Anat Eldar‐Boock
Anat Eldar‐Boock is a scholar working on Biomaterials, Immunology and Allergy, Oncology, Molecular Medicine and Microbiology, having authored 37 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), Nanoplatforms for cancer theranostics (9 papers), Bone health and treatments (5 papers), RNA Interference and Gene Delivery (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Cell Adhesion Molecules Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Reproductive Biology and Fertility (3 papers). The work is most often cited by research in Biomaterials (560 citations), Molecular Medicine (81 citations), Biomedical Engineering (689 citations), Pharmaceutical Science (94 citations) and Microbiology (88 citations). Anat Eldar‐Boock has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Ronit Satchi‐Fainaro, Anna Scomparin, Dina Polyak, Doron Shabat, Galia Tiram, Samer Gnaim, Shiran Ferber, Rachel Blau, Ori Green and Keren Miller. Their work appears in journals such as Journal of Controlled Release, Polymers for Advanced Technologies, Cancer Research, Biomaterials and Advanced Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.